From September 25th-27th, Centerline attended the MedTech Conference, powered by AdvaMed, in San Jose, California. This conference offered us an opportunity to connect with thousands of medical technology professionals and the investing community.
There has undoubtedly been evidence of physician and patient radiation exposure during an endovascular procedure, but what exactly do the statistics look like?
Our IOPS device is well on its way to market entry! Beginning this fall, we’ll be attending various 2017 medical device conferences and events.
Earlier this month, researchers at Mount Sinai Health System performed a study using 3D ultrasound vascular imaging to detect plaque buildup in arteries.
A few members of the Centerline Biomedical team recently attended the Advanced Design & Manufacturing (AD&M) Expo at the Huntington Convention Center in downtown Cleveland.
We are proud to announce that, on March 29th, 2017, Centerline Biomedical, Inc. was approved by the Ohio Third Frontier Commission for a $1.26M Commercial Acceleration Loan Fund (CALF), under the Ohio Third Frontier Program, managed by the State of Ohio’s Development Services Agency (DSA).